News and Features

Session two focused around the work to link multiple national datasets and securely release the datasets for analysis by CGCV researchers.

In session 3, speakers discuss the challenges around cancer genetic variant interpretation and introduce the resources overcoming these.

In session 4, we had an exciting range of talks covering the educational and resource needs for different areas of the clinical community.

Our final session covered the benefit that CGCV outputs are having for patients and how our PPI group are having valuable input to research.

Tuesday 11 February 2020 is International Day of Women and Girls in Science. Here we introduce the women leading CGCV research activities.